Clinical trial
SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease
NCT05765110 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 3, 2023
- Completion date
- December 31, 2026
- Enrollment
- 80 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.